Bi Asset Management Fondsmaeglerselskab A Mirum Pharmaceuticals, Inc. Transaction History
Bi Asset Management Fondsmaeglerselskab A
- $8.88 Billion
- Q1 2025
A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 727 shares of MIRM stock, worth $32,460. This represents 0.0% of its overall portfolio holdings.
Number of Shares
727Holding current value
$32,460% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
225Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$303 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$213 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$145 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$125 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$113 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.64B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...